Loading...
Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma
Na minha lista:
| Udgivet i: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8107630/ https://ncbi.nlm.nih.gov/pubmed/34012679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-230 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|